| PUBCHEM ID |
49765785
|
| UNII |
92R6N6C82N
|
| Preferred Term |
4-(3,4-DICHLOROPHENYL)-7-((1,2,4)TRIAZOLO(1,5-A)PYRIDIN-6-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE, (4S)-
|
| CAS |
1254941-82-6
|
| INCHIKEY |
VXVOMCCQHIVMJK-SFHVURJKSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
Clc(ccc([C@H](CNC1)c(cc2)c1cc2-c1cn2ncnc2cc1)c1)c1Cl
|
| Total Surface Area |
284,37
|
| Relative PSA |
0,14541
|
| TPSA |
42,22
|
| cLogS |
-6,956
|
| MW |
395,292
|
| cLogP |
3,2817
|
| H-Acceptors |
4
|
| H-Donors |
1
|
| Ro5 violations |
0
|
| Druglikeness |
4,0625
|
| DrugScore |
0,457788558337662
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2+
|
| Caco-2 Permeability II |
1,4322
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Inhibitor
|
| CYP450 2C9 Inhibitor |
Inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,232
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,924
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,4963
|
| Carcinogenicity (Three-class) |
Non-required
|